The global breast imaging market is one of the fastest growing multi-billion dollar markets in the healthcare industry with a CAGR of 15.37% reaching about $5 Billion by the year 2017.
(PRWEB) February 26, 2013
The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the Breast Imaging Market scenario.
Breast imaging market is driven majorly by rising numbers of breast cancer cases. Technological revolution to reduce the number of false positives is considered as the second major driver for breast imaging market. Safer sand comfortable imaging procedures with better efficacy and outcome also drive the breast imaging market. Emerging economies such as Asia-pacific and Middle-East and Africa are the future drivers of the breast imaging market.
Inadequate reimbursement policies are the major set-back for the breast imaging market. However, this, too, will likely improve as the technology becomes more available across the globe.
This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service.
The report categorizes the entire breast imaging market into ionizing breast imaging modalities and non-ionizing breast imaging modalities based on the technical aspect of use of radiation. The technologies profiled under ionizing breast imaging modalities are Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI) or Breast Specific Gamma Imaging (BSGI) and Positron Emission Tomography (PET) various non-ionizing breast screening modalities covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
This report will not only cover the technical aspects of the breast imaging modalities, but also provide quantitative data analysis and growth rates for the current and emerging breast cancer screening modalities. A few technologies coupled with other technologies, termed as dual modalities, offers better diagnostic procedures for the patients with dense breasts and high risk of cancer. The combination of spectral and Photonics phenomenon has enabled new breast imaging capabilities, providing clinicians with unique views of the structure and functioning, both at the molecular and cellular levels. The report also tracks the regional adoption and development trends, providing strategic recommendation to stay active and compete in the market space. An impact analysis of major drivers and restraints influencing the growth of the market is mapped for the period of five years.
This study also analyses the competitive scenario of the world breast imaging market and the strategies employed by the key industry participants to develop products and services. Leading players featured include AGFA Healthcare, Aurora Imaging Technology, Dilon Technologies, Dune Medical Devices, Gamma Medica, GE Healthcare, Hologic, Imaging Diagnostic Systems, Koning Corporation, Naviscan, Philips Healthcare, Planmeca, Siemens Healthcare, U Systems, and SonoCine.
For more information please visit http://www.researchandmarkets.com/research/6mrzq8/breast_imaging
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Imaging